Loading...

PE anti-mouse CD80 Antibody

Pricing & Availability
Clone
16-10A1 (See other available formats)
Regulatory Status
RUO
Other Names
B7-1, B7, Ly-53
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
16-10A1_PE_032309.jpg
Thioglycolate-elicited Balb/c mouse peritoneal macrophages stained with 16-10A1 PE
  • 16-10A1_PE_032309.jpg
    Thioglycolate-elicited Balb/c mouse peritoneal macrophages stained with 16-10A1 PE
See PE spectral data
Cat # Size Price Quantity Check Availability Save
104707 50 µg 88€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
104708 200 µg 235€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD80 is a 60 kD highly glycosylated protein. It is a member of the Ig superfamily and is also known as B7-1, B7, and Ly-53. CD80 is constitutively expressed on dendritic cells and monocytes/macrophages, and inducibly expressed on activated B and T cells. The ligation of CD28 on T cells with CD80 and CD86 (B7-2) on antigen presenting cells (such as dendritic cells, macrophages, and B cells) elicits co-stimulation of T cells resulting in enhanced cell activation, proliferation, and cytokine production. CD80 appears to be expressed later in the immune response than CD86. CD80 can also bind to CD152, also known as CTLA-4, to deliver an inhibitory signal to T cells.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
CHO cell line transfected with mouse B7 (CD80)
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation2, in vitro and in vivo blocking of CTLA-4 Ig to CD80 by blocking costimulation of T cells by activated B cells2-4, and immunohistochemical staining of acetone-fixed frozen sections1,4. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 104747-104752).

Application References

(PubMed link indicates BioLegend citation)
  1. Harlan DM, et al. 1994. P. Natl. Acad. Sci. USA 91:3137. (IHC)
  2. Razi-Wolf Z, et al. 1992. P. Natl. Acad. Sci. USA 89:4210. (Block, IP)
  3. Hathcock KS, et al. 1994. J. Exp. Med. 180:631. (Block)
  4. Herold KC, et al. 1997. J. Immunol. 158:984. (Block, IHC)
  5. Ma XT, et al. 2006. Cancer Res. 66:1169.
  6. Andoniou CE, et al. 2005. Nature Immunology 6:1011. (FC)
  7. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  8. Turnquist HR, et al. 2007. J. Immunol. 178:7018.
  9. Misra RS, et al. 2010. J. Exp Med. 207:1775. PubMed
  10. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  11. Philipsen L, et al. 2013. Mol Cell Proteomics. 12:2551. PubMed
Product Citations
  1. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  2. Zhang F, et al. 2017. Mol Immunol. 10.1016/j.molimm.2017.06.019. PubMed
  3. Ye Y, et al. 2017. Sci Immunol. 2:17. PubMed
  4. Bhattacharjee P, et al. 2018. Sci Rep. 13:e0199785. PubMed
  5. Xie Z, et al. 2018. J Am Heart Assoc. 7:e007442. PubMed
  6. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  7. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  8. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  9. Knox T, et al. 2019. Sci Rep. 9:6136. PubMed
  10. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  11. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  12. Lin SY, et al. 2017. Autophagy. 14:778. PubMed
  13. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  14. Kodumudi KN, et al. 2019. Front Immunol. 10:1939. PubMed
  15. Matundan H, et al. 2019. J Virol. 93. PubMed
  16. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  17. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  18. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  19. Mulder R, et al. 2017. Front Immunol. 1.464583333. PubMed
  20. Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed
  21. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  22. Yang C, et al. 2019. Nanomedicine (Lond). 14:2423. PubMed
  23. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  24. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  25. Lightman SM, et al. 2020. Cell Reports. 1.086805556. PubMed
  26. Tsukasaki M, et al. 2020. Cell Reports. 32(10):108124. PubMed
  27. Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed
  28. Rozanski C, et al. 2011. J Exp Med. 208:1435. PubMed
  29. Simmons D, et al. 2012. J Immunol. 188:3116. PubMed
  30. Marshall N, et al. 2012. Cancer Res. 72:581. PubMed
  31. Jeisy-Scott V, et al. 2012. J Virol. 86:10988. PubMed
  32. Wong E, et al. 2012. J Immunol. 189:5667. PubMed
  33. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  34. White C, et al. 2015. J Immunol. 194:697. PubMed
  35. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  36. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  37. Tateishi R, et al. 2015. PLoS One. 10: e0141650. PubMed
  38. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  39. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  40. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  41. Kadir NA, et al. 2020. Pathogens. 9:00. PubMed
  42. Wang X, et al. 2021. EMBO J. 40:e105926. PubMed
  43. Feng S, et al. 2021. Exp Ther Med. 21:20. PubMed
  44. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  45. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  46. Utley A, et al. 2020. Cell Rep. 31:107815. PubMed
  47. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  48. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  49. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  50. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  51. Wei H, et al. 2021. Malar J. 20:89. PubMed
  52. Fan Q, et al. 2021. Bioact Mater. 6:4014. PubMed
  53. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  54. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  55. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  56. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  57. Zhang X, et al. 2021. Front Pharmacol. 12:706748. PubMed
  58. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  59. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
  60. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  61. Wang Y, et al. 2020. Vaccines (Basel). 8:. PubMed
  62. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  63. Ganesan R, et al. 2020. FASEB J. 34:15888. PubMed
  64. Lin YC, et al. 2020. Mol Med Rep. 22:4909. PubMed
  65. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  66. Wu J, et al. 2021. Mol Med Rep. 23:. PubMed
  67. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  68. Li J, et al. 2020. Development. :. PubMed
  69. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  70. Izumi G, et al. 2021. Nat Commun. 12:5029. PubMed
  71. Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed
  72. Piñón-Zárate G, et al. 2022. Molecules. 27:. PubMed
  73. Wu G, et al. 2022. Wellcome Open Res. 6:134. PubMed
  74. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  75. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  76. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  77. Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
  78. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  79. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  80. Kelly SH, et al. 2021. ACS Biomater Sci Eng. 7:1876. PubMed
  81. Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed
  82. Guo L, et al. 2021. Vaccines (Basel). 9:. PubMed
  83. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  84. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  85. Coe D, et al. 2022. JCI Insight. 7:. PubMed
  86. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  87. Zhang X, et al. 2022. JCI Insight. 7:. PubMed
  88. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  89. Vogel A, et al. 2022. STAR Protoc. 3:101653. PubMed
  90. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  91. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  92. Kelly SH, et al. 2021. Adv Healthc Mater. 10:e2001614. PubMed
  93. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  94. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  95. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  96. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  97. Florêncio KGD, et al. 2022. Front Immunol. 13:941757. PubMed
  98. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  99. Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed
  100. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  101. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  102. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  103. Liu M, et al. 2022. Cells. 11: . PubMed
  104. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  105. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  106. Han J, et al. 2023. Front Microbiol. 13:1067725. PubMed
  107. Sohn HS, et al. 2022. Sci Adv. 8:eabo5284. PubMed
  108. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  109. Cheng K, et al. 2023. Small. 19:e2300125. PubMed
  110. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  111. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  112. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  113. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  114. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  115. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  116. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  117. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  118. Wang X, et al. 2023. Stem Cell Rev Rep. . PubMed
RRID
AB_313128 (BioLegend Cat. No. 104707)
AB_313129 (BioLegend Cat. No. 104708)

Antigen Details

Structure
Ig superfamily, 60 kD
Distribution

Macrophages, activated B cells and T cells, dendritic cells

Function
T cell costimulation
Ligand/Receptor
CD28 (stimulatory), CD152(CTLA4) (inhibitory)
Cell Type
B cells, Dendritic cells, Macrophages, T cells, Tregs
Biology Area
Cell Biology, Costimulatory Molecules, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules, Immune Checkpoint Receptors
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Linsley PS, et al. 1991. J. Exp. Med. 174:561.
3. Salomon B, et al. 2001. Annu. Rev. Immunol. 19:225.

Gene ID
12519 View all products for this Gene ID
UniProt
View information about CD80 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 2    Revision Date: 02.18.2013

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account